Title | Author(s) | Issue date | ???itemlist.??? |
The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease | Tzioufas, A. G.; Tzortzakis, N. G.; Panou-Pomonis, E.; Boki, K. A.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology | Raptopoulou, A.; Sidiropoulos, P.; Siakka, P.; Boki, K. A.; Drosos, A. A.; Aslanidis, S.; Karras, D.; Pikazis, D.; Vassilopoulos, D.; Karassa, F.; Boumpas, D. T. | 24-Nov-2015 | - |
Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients | Boki, K. A.; Drosos, A. A.; Tzioufas, A. G.; Lanchbury, J. S.; Panayi, G. S.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients | Boki, K. A.; Panayi, G. S.; Vaughan, R. W.; Drosos, A. A.; Moutsopoulos, H. M.; Lanchbury, J. S. | 24-Nov-2015 | - |
How significant is sensorineural hearing loss in primary Sjogren's syndrome? An individually matched case-control study | Boki, K. A.; Ioannidis, J. P.; Segas, J. V.; Maragkoudakis, P. V.; Petrou, D.; Adamopoulos, G. K.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis | Boletis, J. N.; Ioannidis, J. P.; Boki, K. A.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients | Boki, K. A.; Dafni, U.; Karpouzas, G. A.; Papasteriades, C.; Drosos, A. A.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus | Karassa, F. B.; Ioannidis, J. P.; Boki, K. A.; Touloumi, G.; Argyropoulou, M. I.; Strigaris, K. A.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study | Boki, K. A.; Kurki, P.; Holthofer, H.; Tzioufas, A. G.; Drosos, A. A.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome | Tektonidou, M. G.; Ioannidis, J. P.; Boki, K. A.; Vlachoyiannopoulos, P. G.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide | Ioannidis, J. P.; Boki, K. A.; Katsorida, M. E.; Drosos, A. A.; Skopouli, F. N.; Boletis, J. N.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome | Tektonidou, M. G.; Ioannidis, J. P.; Moyssakis, I.; Boki, K. A.; Vassiliou, V.; Vlachoyiannopoulos, P. G.; Kyriakidis, M. K.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Risk factors for central nervous system involvement in systemic lupus erythematosus | Karassa, F. B.; Ioannidis, J. P.; Touloumi, G.; Boki, K. A.; Moutsopoulos, H. M. | 24-Nov-2015 | - |
Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations | Ioannidis, J. P.; Tarassi, K.; Papadopoulos, I. A.; Voulgari, P. V.; Boki, K. A.; Papasteriades, C. A.; Drosos, A. A. | 24-Nov-2015 | - |